| Q48213465 | A New Orphan Receptor Involved in Pulsatile Growth Hormone Release |
| Q34516154 | A natural variant of obestatin, Q90L, inhibits ghrelin's action on food intake and GH secretion and targets NPY and GHRH neurons in mice |
| Q44267752 | AMPA-sst2 somatostatin receptor interaction in rat hypothalamus requires activation of NMDA and/or metabotropic glutamate receptors and depends on intracellular calcium |
| Q48226597 | An electrophysiological and morphological investigation of the projections of growth hormone-releasing peptide-6-responsive neurons in the rat arcuate nucleus to the median eminence and to the paraventricular nucleus |
| Q33644020 | Brain-endocrine interactions: a microvascular route in the mediobasal hypothalamus. |
| Q73879575 | Cardiac ischemia and impairment of vascular endothelium function in hearts from growth hormone-deficient rats: protection by hexarelin |
| Q48901484 | Central actions of the nonpeptide growth hormone secretagogue GHS-25. |
| Q30435969 | Deterministic construct of amplifying actions of ghrelin on pulsatile growth hormone secretion |
| Q43588266 | Do growth hormone-releasing peptides act as ghrelin secretagogues? |
| Q60674335 | Effects of GHRP-2 and Hexarelin, Two Synthetic GH-Releasing Peptides, on GH, Prolactin, ACTH and Cortisol Levels in Man. Comparison with the Effects of GHRH, TRH and hCRH |
| Q51982894 | Estimation of parameters for a mathematical model of growth hormone secretion. |
| Q42489529 | Evidence for a role of the GHS-R1a receptors in ghrelin inhibition of gastric acid secretion in the rat. |
| Q44435861 | GH-releasing peptide (GHRP-6)-induced ACTH release in patients with Addison’s disease: Effect of glucocorticoid withdrawal |
| Q37275590 | Ghrelin signalling on food reward: a salient link between the gut and the mesolimbic system |
| Q31162633 | Ghrelin treatment reverses the reduction in weight gain and body fat in gastrectomised mice |
| Q46112477 | Ghrelin's control of food reward and body weight in the lateral hypothalamic area is sexually dimorphic |
| Q90328862 | Ghrelin's effects on food motivation in rats are not limited to palatable foods |
| Q28081062 | Ghrelin. |
| Q36025681 | Ghrelin: a link between eating disorders, obesity and reproduction. |
| Q34085744 | Ghrelin: an orexigenic and somatotrophic signal from the stomach |
| Q36637152 | Ghrelin: central and peripheral implications in anorexia nervosa |
| Q41613922 | Glutamatergic regulation of ghrelin-induced activation of the mesolimbic dopamine system |
| Q73422369 | Growth hormone (GH) response to GH-releasing peptide-6 in patients with insulin-dependent diabetes mellitus |
| Q33701462 | Growth hormone (GH) secretagogues and neuroendocrine regulation of GH secretion |
| Q34035420 | Growth hormone secretagogues: mechanism of action and use in aging |
| Q42452406 | Growth hormone secretion elicited by GHRH, GHRP-6 or GHRH plus GHRP-6 in patients with microprolactinoma and macroprolactinoma before and after bromocriptine therapy |
| Q72797835 | Growth hormone-releasing activity of hexarelin in humans. A dose-response study |
| Q36455914 | Gut peptides and the regulation of appetite. |
| Q35132233 | Hedonic and incentive signals for body weight control |
| Q38461022 | Hexarelin-induced growth hormone response in short stature. Comparison with growth hormone-releasing hormone plus pyridostigmine and arginine plus estrogen |
| Q41730817 | Hypothalamic and hypophyseal regulation of growth hormone secretion |
| Q28291920 | Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins |
| Q48901465 | Interactions of growth hormone secretagogues and growth hormone-releasing hormone/somatostatin |
| Q30307314 | Interactive regulation of postmenopausal growth hormone insulin-like growth factor axis by estrogen and growth hormone-releasing peptide-2. |
| Q52625359 | Lateral septum growth hormone secretagogue receptor affects food intake and motivation for sucrose reinforcement. |
| Q48820746 | Mechanisms underlying the negative growth hormone (GH) autofeedback on the GH-releasing effect of hexarelin in man. |
| Q42671136 | Molecular cloning and gene expression of growth hormone-releasing peptide receptor in rat tissues |
| Q34635506 | Neuroendocrine and peripheral activities of ghrelin: implications in metabolism and obesity |
| Q48330103 | Novel hexarelin analogs stimulate feeding in the rat through a mechanism not involving growth hormone release |
| Q42046981 | Relationship between gut and sepsis: Role of ghrelin |
| Q24619885 | Role of ghrelin in food reward: impact of ghrelin on sucrose self-administration and mesolimbic dopamine and acetylcholine receptor gene expression |
| Q30701059 | Skeletal growth acceleration with growth hormone secretagogues in transgenic growth retarded rats: pattern-dependent effects and mechanisms of desensitization. |
| Q44185826 | Sleep in mice with nonfunctional growth hormone-releasing hormone receptors |
| Q48138641 | The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants. |
| Q48493013 | The nonpeptide growth hormone secretagogue, MK-0677, activates hypothalamic arcuate nucleus neurons in vivo |
| Q37381848 | The role of liver-derived insulin-like growth factor-I. |
| Q33624632 | Therapeutic Potential of Targeting the Ghrelin Pathway |
| Q77681773 | [New growth hormone secretagogues: from physiology to the first therapeutic applications] |